cbdMD (NYSEAMERICAN:YCBD) Trading 8.6% Higher

cbdMD, Inc. (NYSEAMERICAN:YCBDGet Free Report)’s share price rose 8.6% during trading on Thursday . The company traded as high as $1.04 and last traded at $1.00. Approximately 69,687 shares changed hands during trading, a decline of 74% from the average daily volume of 271,512 shares. The stock had previously closed at $0.92.

cbdMD Stock Up 8.6 %

The stock has a market cap of $3.05 million, a P/E ratio of -0.08 and a beta of 2.15.

cbdMD (NYSEAMERICAN:YCBDGet Free Report) last released its quarterly earnings results on Tuesday, February 13th. The company reported ($0.67) earnings per share (EPS) for the quarter. cbdMD had a negative net margin of 87.07% and a negative return on equity of 118.28%. The firm had revenue of $5.38 million for the quarter.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of YCBD. AXS Investments LLC increased its stake in shares of cbdMD by 42.1% in the 4th quarter. AXS Investments LLC now owns 91,204 shares of the company’s stock worth $95,000 after purchasing an additional 27,017 shares in the last quarter. Renaissance Technologies LLC grew its holdings in cbdMD by 49.3% during the first quarter. Renaissance Technologies LLC now owns 93,600 shares of the company’s stock valued at $97,000 after purchasing an additional 30,900 shares during the period. Vident Investment Advisory LLC increased its position in cbdMD by 68.4% in the first quarter. Vident Investment Advisory LLC now owns 119,283 shares of the company’s stock worth $124,000 after buying an additional 48,470 shares in the last quarter. Prudential Financial Inc. bought a new position in shares of cbdMD in the second quarter worth about $32,000. Finally, Vanguard Group Inc. raised its stake in shares of cbdMD by 11.9% in the third quarter. Vanguard Group Inc. now owns 1,304,682 shares of the company’s stock worth $294,000 after buying an additional 139,081 shares during the period. Hedge funds and other institutional investors own 7.18% of the company’s stock.

cbdMD Company Profile

(Get Free Report)

cbdMD, Inc produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids.

Featured Stories

Receive News & Ratings for cbdMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for cbdMD and related companies with MarketBeat.com's FREE daily email newsletter.